Navigation Links
Food, Drug, Medical Device Recalls Continue to Climb According to ExpertRECALL Quarterly Index
Date:11/3/2011

INDIANAPOLIS, Nov. 3, 2011 /PRNewswire/ -- Food recalls in the third quarter affected nearly six times as many units as the previous three-month period, according to the quarterly ExpertRECALL™ Index, released today. The ExpertRECALL Index also found that pharmaceutical and medical device recalls increased while recalls for children's and infants' products and consumer goods hit surprising five-quarter lows.

(Photo: http://photos.prnewswire.com/prnh/20111103/PH99443)

Undeclared allergens remained the leading factor in initiating food recalls, as more than 50 percent of all food products were recalled for this reason during the third quarter. Listeria-related recalls were the second-leading cause, accounting for 25 percent of all food recalls listed on the U.S. Food and Drug Administration's website between July and September.

"Based on third-quarter recall activity, product safety remains a hot topic among consumers, manufacturers, retailers and regulators," said Mike Rozembajgier, Vice President of Recalls at Stericycle ExpertRECALL. "Now, as we enter the holiday season, everyone should be reminded of their role in supporting consumer safety to make sure that not only the products we use, but also the gifts we give, are safe for everyone."

"Manufacturers and retailers must pay close attention to consumer safety and be more diligent when communicating with consumers, particularly as shoppers increase their purchases during the holiday season," added Rozembajgier. "And while regulators will need to pay close attention to product safety complaints, particularly about the hottest gifts of the season, consumers need to keep their eyes and ears open for recall announcements about not only the products they buy for themselves, but also about the gifts they are giving."

Burn hazards and structural-collapse risks replaced laceration concerns as the main causes of consumer product recalls during the third quarter as recalls in this category dropped 20 percent from the previous quarter. Children's and infant product recalls decreased for the third straight quarter, also recording a five-quarter low. More than 40 percent of these recalls were initiated by the CPSC out of a concern for the choking risk associated with small parts, the primary cause of recalls in this category.

According to FDA Enforcement reports, 16 percent fewer pharmaceutical units were affected compared to the second quarter of 2011, despite an increase in the number of recall events in the third quarter.

The ExpertRECALL Index also tracks medical device recalls as documented in FDA Enforcement Reports, revealing a modest increase in recalls in the third quarter compared to the average number of recalls in the prior two quarters. Third-quarter recalls involved nearly double the number of units compared to the second quarter.

The 2011 third-quarter ExpertRECALL Index is the only report that aggregates and tracks cumulative recall data from the CPSC and the FDA. Stericycle ExpertRECALL compiles the ExpertRECALL Index from data issued by the U.S. Food and Drug Administration and the Consumer Product Safety Commission. The ExpertRECALL Index report is available online at http://www.expertrecall.com/recallindex.

About Stericycle ExpertRECALL™

Stericycle ExpertRECALL™ is the industry leader in managing consumer product, pharmaceutical, medical device, juvenile product, and food and beverage recalls. Stericycle ExpertRECALL streamlines the entire product recall process and manages Notification & Response, Processing & Tracking, and Compliance & Reporting for a variety of companies. For more information, visit http://www.expertrecall.com.

 


'/>"/>
SOURCE Stericycle ExpertRECALL
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Poll: 74% Support Banning Sale of Expired Baby Food, Formula and Over-the-Counter Meds
2. International Medical Corps Team in Hardest-Hit Coastal Communities Finds Severe Shortages of Food, Water, Medicines; Acute Need for Mental Health Support
3. Tickets On Sale Now: Bridge to Hope All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Masons Great Meadow
4. Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial
5. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
6. The Colorado Institute for Drug, Device and Diagnostic Development Announces Companies Selected From Its First Solicitation: Sophono, Inc., Receiving $600K; and PeptiVir, Inc., $300K
7. Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001
8. Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland
9. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
10. Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL
11. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
(Date:2/4/2016)... 2016 In response to the opioid abuse epidemic, ... for Medical Products and Tobacco, along with other FDA leaders, ... approach to opioid medications. The plan will focus on policies ... pain access to effective relief. --> ... Re-examine the risk-benefit paradigm for opioids and ensure that the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King Kullen! ... assortments and packaging. This staple for Valentine’s Day is a must-have, and can be ... Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, elegantly ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... of Popeyes Louisiana Kitchen restaurants, launched the 14th annual “Appetite for a Cure” ... adults with muscular dystrophy, ALS and related diseases that severely limit strength and ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... poised to once again host, Swirl, A Wine Tasting Event at the La ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced ... and donate to Give To Cure’s campaign that is crowdfunding clinical trials to help ... and share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion ...
(Date:2/5/2016)... ... 2016 , ... Stuart Bentkover, MD, FACS is thrilled to announce ... most effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts ... PicoSure has been approved by the Food and Drug Administration (FDA) as a safe ...
Breaking Medicine News(10 mins):